CoChat

An Editorial Update: Annus horribilis for Vitamin E

Guallar, Eliseo, Hanley, Daniel F., Miller, Edgar R. · 2005 · Annals of Internal Medicine
Cited by 34

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Editorials19 July 2005An Editorial Update: Annus horribilis for Vitamin EEliseo Guallar, MD, DrPH, Daniel F. Hanley, MD, and Edgar R. Miller III, MD, PhDEliseo Guallar, MD, DrPHFrom Johns Hopkins University Bloomberg School of Public Health, Johns Hopkins Medical Institutions, Baltimore, MD 21205., Daniel F. Hanley, MDFrom Johns Hopkins University Bloomberg School of Public Health, Johns Hopkins Medical Institutions, Baltimore, MD 21205., and Edgar R. Miller III, MD, PhDFrom Johns Hopkins University Bloomberg School of Public Health, Johns Hopkins Medical Institutions, Baltimore, MD 21205.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-143-2-200507190-00014 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In January 2005, we published a dose–response meta-analysis showing that high-dosage (≥400 IU/d) vitamin E supplementation was associated with a small but statistically significant increased risk for mortality (relative risk, 1.04 [95% CI, 1.01 to 1.07]) (1). The precise dosage of vitamin E at which the relative risk for mortality exceeded 1 and the magnitude of the risk increase were uncertain. However, the analysis showed that high-dosage vitamin E supplementation was likely to be harmful. Even in the best case, it offered no benefit in prolonging life. These findings were highly controversial: Together with our response, this issue of Annals ...References1. Miller ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37-46. [PMID: 15537682] LinkGoogle Scholar2. Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, et al. A randomized trial of E in the primary prevention of cardiovascular disease in 39,876 women: The Women's Health Study. American College of Cardiology Annual Scientific Session, 7 March 2005. Accessed at www.acc05online.acc.org/highlights/keyLectures.aspx?sessionId=8030&&date=7 on 11 June 2005. Google Scholar3. Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized, controlled trial. JAMA. 2005;293:1338-47. [PMID: 15769967] CrossrefMedlineGoogle Scholar4. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:154-60. [PMID: 10639540] CrossrefMedlineGoogle Scholar5. Jiang XC, Li Z, Liu R, Yang XP, Pan M, Lagrost L, et al. Phospholipid transfer protein deficiency impairs apolipoprotein-B secretion from hepatocytes by stimulating a proteolytic pathway through a relative deficiency of vitamin E and an increase in intracellular oxidants. J Biol Chem. 2005;280:18336-40. [PMID: 15734742] CrossrefMedlineGoogle Scholar6. Colas S, Germain E, Arab K, Maheo K, Goupille C, Bougnoux P. Alpha-tocopherol suppresses mammary tumor sensitivity to anthracyclines in fish oil-fed rats. Nutr Cancer. 2005;51:178-83. [PMID: 15860440] CrossrefMedlineGoogle Scholar7. Berman K, Brodaty H. Tocopherol (vitamin E) in Alzheimer's disease and other neurodegenerative disorders. CNS Drugs. 2004;18:807-25. [PMID: 15377170] CrossrefMedlineGoogle Scholar8. Butterfield DA, Castegna A, Drake J, Scapagnini G, Calabrese V. Vitamin E and neurodegenerative disorders associated with oxidative stress. Nutr Neurosci. 2002;5:229-39. [PMID: 12168685] CrossrefMedlineGoogle Scholar9. Grundman M, Grundman M, Delaney P. Antioxidant strategies for Alzheimer's disease. Proc Nutr Soc. 2002;61:191-202. [PMID: 12133201] CrossrefMedlineGoogle Scholar10. Luchsinger JA, Mayeux R. Dietary factors and Alzheimer's disease. Lancet Neurol. 2004;3:579-87. [PMID: 15380154] CrossrefMedlineGoogle Scholar11. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med. 1997;336:1216-22. [PMID: 9110909] CrossrefMedlineGoogle Scholar12. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. 2005;352:2379-88 N Engl J Med. . [PMID: 15829527] CrossrefMedlineGoogle Scholar13. Clegg A, Bryant J, Nicholson T, McIntyre L, DeBroe S, Gerard K, et al. Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease. A systematic review. Int J Technol Assess Health Care. 2002;18:497-507. [PMID: 12391943] CrossrefMedlineGoogle Scholar14. Birks JS, Harvey R. Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst Rev. 2003;:001190. [PMID: 12917900] MedlineGoogle Scholar15. Graf M, Ecker D, Horowski R, Kramer B, Riederer P, Gerlach M, et al. High dose vitamin E therapy in am

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-143-2-200507190-00014

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 34

Metadata

Authors
Guallar, E., Hanley, D. F., & Miller, E. R.
Venue
Annals of Internal Medicine
Published
2005-07-19
Volume
143
Issue
2
Pages
143-145
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2028015946
Cited by
34
References
6
FWCI
3.14
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An Editorial Update: Annus horribilis for Vitamin E. https://app.cochat.ai/papers/10.7326/0003-4819-143-2-200507190-00014
The paper
Guallar, E., Hanley, D. F., & Miller, E. R. (2005). An Editorial Update: Annus horribilis for Vitamin E. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-143-2-200507190-00014

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.